How large is the acne vulgaris market, and what is its growth trajectory?
The acne vulgaris market size has grown strongly in recent years. It will grow from $7.94 billion in 2024 to $8.47 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the rising prevalence of acne, consumer preference for natural ingredients, expansion of online retail channels, investment in research and development, and increased availability of over-the-counter products.
The acne vulgaris market size is expected to see strong growth in the next few years. It will grow to $10.89 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growing awareness of skincare, rising teenage population, focus on self-care and wellness, rising incidence of adult acne, telemedicine, and e-commerce expansion. Major trends in the forecast period include technological advancements, the launch of advanced drugs, innovative products, growing clinical approval, and innovations in novel medical processes.
Get Your Free Sample of The Global Acne Vulgaris Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21075&type=smp
What are the key forces behind the acne vulgaris market’s growth in recent years?
The increasing demand for skincare products is expected to propel the growth of the acne vulgaris market going forward. Skincare products are formulations designed to enhance the health and appearance of the skin. They include a wide range of items that address different skin concerns, from cleansing to moisturizing and protection. The increasing demand for skincare products is due to social media influence, rising dermatological concerns, product innovations, and a shift toward preventive skincare drive the growing awareness of skincare. Acne vulgaris treatment is supported by skincare products that target the root causes of the condition, such as excess sebum production, clogged pores, and bacterial growth, through the use of ingredients like salicylic acid, benzoyl peroxide, and retinoids, which help to exfoliate the skin, reduce inflammation, and promote clearer, healthier skin. For instance, in August 2024, according to The Cosmetic, Toiletry and Perfumery Association (CTPA), a UK-based non-profit organization, the European cosmetics market was valued at €96 billion (approximately $105 billion) at retail sales price (RSP) in 2023, making it one of the world’s largest alongside the USA. This reflects growth from €88 billion (approximately $93 billion) RSP in 2022. Therefore, rising awareness of skincare is driving the acne vulgaris market.
What are the major segments of the acne vulgaris market?
The acne vulgaris market covered in this report is segmented –
1) By Type: Systemic Therapy, Hormonal Therapy, Physical Treatment, Topical Combination Therapy, Other Types
2) By Age Group: 10 To 17 Years, 18 To 44 Years, 45 To 64 Years, 65 Years And Above
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Systemic Therapy: Oral Antibiotics, Oral Retinoids, Oral Anti-Inflammatory Agents
2) By Hormonal Therapy: Oral Contraceptives, Androgen Receptor Inhibitors
3) By Physical Treatment: Laser Therapy, Light-Based Therapy, Chemical Peels, Microdermabrasion
4) By Topical Combination Therapy: Retinoid And Antibiotic Combinations, Benzoyl Peroxide And Antibiotic Combinations, Retinoid And Benzoyl Peroxide Combinations
5) By Other Types: Herbal And Natural Remedies, Biologic Therapies, Emerging Therapies
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/acne-vulgaris-global-market-report
Which companies dominate the acne vulgaris market?
Major companies operating in the acne vulgaris market are Pfizer Inc., Johnson and Johnson, AbbVie Inc., L’Oréal Paris, GlaxoSmithKline Plc., Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals, Bausch Healh Companies, Sun Pharmaceutical Industries Ltd., Incyte, Aurobindo Pharma, Lupin Ltd., Torrent Pharmaceuticals, Biocon, Stiefel Laboratories, Mayne Pharma Group Limited, Paratek Pharmaceuticals, Cosmo Pharmaceuticals, AOBiome
What major trends will shape the acne vulgaris market during the forecast period?
Major companies operating in the acne vulgaris market are focusing on developing innovative solutions such as triple-combination topical treatment to provide a simplified, once-daily triple-combination topical treatment for acne vulgaris. A triple-combination topical treatment is a formulation that combines three active ingredients, typically targeting different aspects of a condition, to provide enhanced therapeutic effects in managing skin disorders like acne or psoriasis. For instance, in October 2023, Bausch Health Companies Inc., a Canada-based pharmaceutical company, announced a Food and Drug Administration (FDA) approval for Cabtreo (clindamycin phosphate, adapalene, and benzoyl peroxide). This topical gel is designed for the treatment of acne vulgaris in patients aged 12 years and older. This innovative formulation combines an antibiotic, a retinoid, and an antibacterial agent to effectively target acne lesions and prevent future breakouts. Cabtreo offers a convenient application method and demonstrates a favorable safety profile for a wide range of patients.
What are the key regional dynamics of the acne vulgaris market, and which region leads in market share?
North America was the largest region in the acne vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acne vulgaris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Acne Vulgaris Market Report 2025 Offer?
The acne vulgaris market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Acne vulgaris is a common chronic inflammatory skin condition primarily affecting the pilosebaceous units, characterized by the formation of comedones, papules, pustules, nodules, and cysts, often triggered by factors such as excess sebum production, follicular hyperkeratinization, Cutibacterium acnes proliferation, and inflammation, typically occurring on the face, chest, and back, with varying severity and potential for scarring.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21075
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
